Abivax SA (France) Top Management
ABVX Stock | EUR 8.44 0.24 2.93% |
Abivax SA employs about 24 people. The company is managed by 10 executives with a total tenure of roughly 13 years, averaging almost 1.0 years of service per executive, having 2.4 employees per reported executive. Analysis of Abivax SA's management performance can provide insight into the company performance.
Alexandra Pearce President Vice President and Head of Regulatory Affairs |
Abivax |
Abivax SA Management Team Effectiveness
The company has return on total asset (ROA) of (0.4368) % which means that it has lost $0.4368 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (12.8647) %, meaning that it generated substantial loss on money invested by shareholders. Abivax SA's management efficiency ratios could be used to measure how well Abivax SA manages its routine affairs as well as how well it operates its assets and liabilities.Abivax SA Workforce Comparison
Abivax SA is rated fifth in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 439. Abivax SA holds roughly 24.0 in number of employees claiming about 5% of equities under Health Care industry.
Abivax SA Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Abivax SA Price Series Summation is a cross summation of Abivax SA price series and its benchmark/peer.
Abivax SA Notable Stakeholders
An Abivax SA stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Abivax SA often face trade-offs trying to please all of them. Abivax SA's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Abivax SA's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Alexandra Pearce | Vice President and Head of Regulatory Affairs | Profile | |
Didier Blondel | CFO, Board Secretary | Profile | |
Alain Chevallier | Advisor | Profile | |
Philippe MD | Founder Director | Profile | |
Regina Jehle | VP Communications | Profile | |
Prof Ehrlich | Chief Officer | Profile | |
Paul Gineste | VP Operations | Profile | |
Anne Pascard | HR Mang | Profile | |
Raquel Lizarraga | Investor Mang | Profile | |
Pierre MBA | Chief Devel | Profile |
About Abivax SA Management Performance
The success or failure of an entity such as Abivax SA often depends on how effective the management is. Abivax SA management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Abivax management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Abivax management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
ABIVAX Socit Anonyme, a biotechnology company, develops, markets, and commercializes anti-viral therapies and therapeutic vaccines for the treatment of infectious diseases in Asia and Latin America. The company was incorporated in 2013 and is headquartered in Paris, France. ABIVAX is traded on Paris Stock Exchange in France.
Please note, the presentation of Abivax SA's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Abivax SA's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Abivax SA's management manipulating its earnings.
Abivax SA Workforce Analysis
Traditionally, organizations such as Abivax SA use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Abivax SA within its industry.Abivax SA Manpower Efficiency
Return on Abivax SA Manpower
Revenue Per Employee | 1.5K | |
Revenue Per Executive | 3.7K | |
Net Loss Per Employee | 1.7M | |
Net Loss Per Executive | 4.1M | |
Working Capital Per Employee | 1.2M | |
Working Capital Per Executive | 3M |
Complementary Tools for Abivax Stock analysis
When running Abivax SA's price analysis, check to measure Abivax SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abivax SA is operating at the current time. Most of Abivax SA's value examination focuses on studying past and present price action to predict the probability of Abivax SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abivax SA's price. Additionally, you may evaluate how the addition of Abivax SA to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |